Mary Beckerle C.'s most recent trade in Exelixis Inc was a trade of 8,354 Common Stock done at an average price of $23.2 . Disclosure was reported to the exchange on Feb. 14, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
Exelixis Inc | Mary C. Beckerle | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 23.24 per share. | 14 Feb 2025 | 8,354 | 42,616 (0%) | 0% | 23.2 | 194,147 | Common Stock |
Exelixis Inc | Mary C. Beckerle | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 14 Feb 2025 | 8,354 | 22,494 | - | - | Option (right to buy) | |
Exelixis Inc | Mary C. Beckerle | Director | Sale of securities on an exchange or to another person at price $ 34.87 per share. | 14 Feb 2025 | 8,354 | 34,262 (0%) | 0% | 34.9 | 291,304 | Common Stock |
Exelixis Inc | Mary C. Beckerle | Director | Sale of securities on an exchange or to another person at price $ 34.90 per share. | 14 Feb 2025 | 3,856 | 30,406 (0%) | 0% | 34.9 | 134,574 | Common Stock |
Huntsman Corp | Mary C. Beckerle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Feb 2025 | 9,717 | 9,717 (0%) | 0% | 0 | Common Stock | |
Huntsman Corp | Mary C. Beckerle | Director | Sale of securities on an exchange or to another person at price $ 21.42 per share. | 06 Nov 2024 | 20,201 | 0 (0%) | 0% | 21.4 | 432,726 | Common Stock |
Exelixis Inc | Mary C. Beckerle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 May 2024 | 18,838 | 34,262 (0%) | 0% | 0 | Common Stock | |
Johnson & Johnson | Mary C. Beckerle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Apr 2024 | 1,385 | 13,643 | - | - | Deferred Share Units | |
Huntsman Corp | Mary C. Beckerle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2024 | 6,895 | 20,201 (0%) | 0% | 0 | Common Stock | |
Exelixis Inc | Mary Beckerle C. | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 30,848 | 30,848 | - | - | Option (right to buy) | |
Exelixis Inc | Mary C. Beckerle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jan 2024 | 15,424 | 15,424 (0%) | 0% | 0 | Common Stock | |
Johnson & Johnson | Mary C. Beckerle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 27 Apr 2023 | 1,193 | 11,896 | - | - | Deferred Share Units | |
Huntsman Corp | Mary C. Beckerle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2023 | 4,700 | 13,306 (0%) | 0% | 0 | Common Stock | |
Huntsman Corp | Mary C. Beckerle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2022 | 3,533 | 8,606 (0%) | 0% | 0 | Common Stock | |
Johnson & Johnson | Mary C. Beckerle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Feb 2022 | 1,175 | 10,355 | - | - | Deferred Share Units | |
Huntsman Corp | Mary C. Beckerle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2021 | 5,073 | 5,073 (0%) | 0% | 0 | Common Stock | |
Johnson & Johnson | Mary C. Beckerle | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Feb 2021 | 1,123 | 8,950 | - | - | Deferred Share Units | |
Huntsman Corp | Mary C. Beckerle | Director | Sale of securities on an exchange or to another person at price $ 26.17 per share. | 24 Nov 2020 | 15,251 | 2,000 (0%) | 0% | 26.2 | 399,180 | Common Stock |